Amylyx Pharmaceuticals previously treated ALS using AMX0035 and gained approval in Canada.
1 report, 1 independent
Updated Aug 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amylyx Pharmaceuticals previously treated ALS using AMX0035 and gained approval in Canada.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amylyx Pharmaceuticals
American biopharmaceutical company
Nothing else this week.
-
Als
river in Vienna
Nothing else this week.
Related events
- Inceptua Group and TikoMed AB are collaborating on an investigational drug for progressive neurodegenerative disorders, including ALS.
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.
- Amylyx Pharmaceuticals shares surged following the announcement of successful clinical trial results.
Coverage
Newest first; wire copies grouped- Pharmaceutical TechnologyAmylyx culls rare neurological disorder programme after trial failure Amylyx Pharmaceuticals has discontinued a clinical programme evaluating a neuronal cell death inhibitor as a result of disappoint